Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,900 | 83 | 98.3% |
| Education | $32.13 | 3 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $339.41 | 19 | $0 (2024) |
| Novo Nordisk Inc | $300.24 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $286.19 | 12 | $0 (2024) |
| Exact Sciences Corporation | $250.31 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $109.33 | 5 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $100.26 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $96.33 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $95.31 | 5 | $0 (2024) |
| ABBVIE INC. | $87.43 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $67.66 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $412.64 | 20 | Exact Sciences Corporation ($120.84) |
| 2023 | $650.71 | 32 | Lilly USA, LLC ($137.88) |
| 2022 | $249.97 | 15 | AstraZeneca Pharmaceuticals LP ($74.99) |
| 2021 | $127.74 | 3 | AstraZeneca Pharmaceuticals LP ($97.02) |
| 2020 | $35.60 | 2 | Lilly USA, LLC ($21.98) |
| 2019 | $73.47 | 4 | Lilly USA, LLC ($57.91) |
| 2018 | $82.30 | 5 | Lilly USA, LLC ($38.15) |
| 2017 | $299.93 | 5 | Novo Nordisk Inc ($118.12) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: VACCINE | ||||||
| 10/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Inflammation | ||||||
| 07/17/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: VACCINE | ||||||
| 06/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Oncology | ||||||
| 05/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: Oncology | ||||||
| 03/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: VACCINE | ||||||
| 02/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Respiratory | ||||||
| 02/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: DIABETES | ||||||
| 01/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Diabetes | ||||||
| 01/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Inflammation | ||||||
| 12/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Oncology | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,054 | 1,365 | $286,723 | $64,286 |
| 2022 | 13 | 1,286 | 1,633 | $340,288 | $92,558 |
| 2021 | 14 | 1,345 | 1,700 | $352,651 | $120,585 |
| 2020 | 14 | 1,368 | 1,859 | $395,444 | $124,754 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 190 | 190 | $56,240 | $25,791 | 45.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 132 | 132 | $38,940 | $11,070 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 282 | $83,190 | $10,565 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 292 | $59,860 | $8,462 | 14.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 74 | 133 | $28,595 | $3,511 | 12.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 178 | 181 | $13,937 | $1,588 | 11.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,890 | $1,365 | 72.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 42 | 42 | $1,861 | $897.90 | 48.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 30 | 30 | $1,200 | $590.70 | 49.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $800.00 | $374.11 | 46.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 21 | $210.00 | $71.61 | 34.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 212 | 212 | $62,752 | $29,545 | 47.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 206 | 206 | $60,770 | $17,977 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 310 | $91,450 | $16,912 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 301 | $61,705 | $12,576 | 20.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 80 | 128 | $27,520 | $5,281 | 19.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 11 | $7,425 | $2,653 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 188 | 201 | $15,477 | $1,847 | 11.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 47 | 47 | $2,115 | $1,494 | 70.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 72 | 72 | $2,880 | $1,431 | 49.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 59 | 59 | $2,360 | $1,184 | 50.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 51 | 51 | $2,244 | $1,033 | 46.1% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 17 | 18 | $3,420 | $565.87 | 16.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 15 | 17 | $170.00 | $58.51 | 34.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 213 | 382 | $112,690 | $31,199 | 27.7% |
About Dr. Ragia Saikali, MD
Dr. Ragia Saikali, MD is a Internal Medicine healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2008. The National Provider Identifier (NPI) number assigned to this provider is 1750569828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ragia Saikali, MD has received a total of $1,932 in payments from pharmaceutical and medical device companies, with $412.64 received in 2024. These payments were reported across 86 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,900).
As a Medicare-enrolled provider, Saikali has provided services to 5,053 Medicare beneficiaries, totaling 6,557 services with total Medicare billing of $402,182. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Baltimore, MD
- Active Since 01/31/2008
- Last Updated 03/09/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1750569828
Products in Payments
- FARXIGA (Drug) $256.31
- Cologuard Collection Kit (Device) $250.31
- MOUNJARO (Drug) $162.43
- Victoza (Drug) $125.46
- TRELEGY ELLIPTA (Drug) $109.33
- VRAYLAR (Drug) $102.99
- WATCHMAN DEVICE (Device) $100.26
- Ozempic (Drug) $98.12
- JARDIANCE (Drug) $70.58
- Rybelsus (Drug) $70.13
- ELIQUIS (Drug) $67.66
- BASAGLAR (Drug) $64.44
- GARDASIL (Biological) $58.94
- EMGALITY (Drug) $47.23
- TRULICITY (Drug) $39.04
- LYVISPAH (Drug) $37.73
- PNEUMOVAX 23 (Biological) $37.39
- Vascepa (Drug) $31.24
- BREZTRI (Drug) $29.88
- Otezla (Drug) $29.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Baltimore
Dr. Shawn Kwatra, M.d, M.D
Internal Medicine — Payments: $978,358
Dr. Aloke Finn, Md, MD
Internal Medicine — Payments: $742,722
David Sidransky, M.d, M.D
Internal Medicine — Payments: $519,965
Dr. Shawn Dhillon, M.d, M.D
Internal Medicine — Payments: $495,197
Mark Levis, M.d, M.D
Internal Medicine — Payments: $450,553
Mark Sulkowski, M.d, M.D
Internal Medicine — Payments: $397,288